| Michelle Murray, MD | |
|
300 Commercial Drive, Alexandria, KY 41001 | |
| (859) 635-9440 | |
| (859) 448-2622 |
| Full Name | Michelle Murray |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 41 Years |
| Location | 300 Commercial Drive, Alexandria, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467497420 | NPI | - | NPPES |
| P00810642 | Other | RAILROAD MEDICARE | |
| 0101188 | Medicaid | OH | |
| 080092523 | Other | KY | RAILROAD MEDICARE |
| 64237506 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 23750 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Rehabilitation Services, Inc. | 8224096474 | 59 |
| Summit Medical Group, Inc | 2163326240 | 693 |
News Archive
Pumps implanted into the chest to maintain circulation can significantly extend the lives of the sickest patients in end-stage heart failure who are not candidates for heart transplantation, according to the results of a clinical trial led by Duke University Medical Center cardiologists.
The past 25 years have seen a significant increase in student participation in high school athletics. Studies have revealed that 2 million injuries, 500,000 doctor visits and 30,000 hospitalizations occur each year among high school athletes.
With many women still searching for the perfect birth control method, a systematic review analyzes a host of studies comparing the contraceptive skin patch or vaginal ring to the pill.
Researchers at Columbia University Medical Center have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body. The study, published in the journal Cell, could help researchers create drugs that are more efficient and less prone to side effects, suggest ways to regulate a drug's activity, and identify novel therapeutic uses for new and existing compounds.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
› Verified 4 days ago
| Entity Name | Summit Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026169 PECOS PAC ID: 2163326240 Enrollment ID: O20031120000738 |
News Archive
Pumps implanted into the chest to maintain circulation can significantly extend the lives of the sickest patients in end-stage heart failure who are not candidates for heart transplantation, according to the results of a clinical trial led by Duke University Medical Center cardiologists.
The past 25 years have seen a significant increase in student participation in high school athletics. Studies have revealed that 2 million injuries, 500,000 doctor visits and 30,000 hospitalizations occur each year among high school athletes.
With many women still searching for the perfect birth control method, a systematic review analyzes a host of studies comparing the contraceptive skin patch or vaginal ring to the pill.
Researchers at Columbia University Medical Center have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body. The study, published in the journal Cell, could help researchers create drugs that are more efficient and less prone to side effects, suggest ways to regulate a drug's activity, and identify novel therapeutic uses for new and existing compounds.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Murray, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (859) 635-9440 | Michelle Murray, MD 300 Commercial Drive, Alexandria, KY 41001 Ph: (859) 635-9440 |
News Archive
Pumps implanted into the chest to maintain circulation can significantly extend the lives of the sickest patients in end-stage heart failure who are not candidates for heart transplantation, according to the results of a clinical trial led by Duke University Medical Center cardiologists.
The past 25 years have seen a significant increase in student participation in high school athletics. Studies have revealed that 2 million injuries, 500,000 doctor visits and 30,000 hospitalizations occur each year among high school athletes.
With many women still searching for the perfect birth control method, a systematic review analyzes a host of studies comparing the contraceptive skin patch or vaginal ring to the pill.
Researchers at Columbia University Medical Center have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body. The study, published in the journal Cell, could help researchers create drugs that are more efficient and less prone to side effects, suggest ways to regulate a drug's activity, and identify novel therapeutic uses for new and existing compounds.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.
› Verified 4 days ago
Stephen M Scott, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Commercial Drive, Alexandria, KY 41001 Phone: 859-635-9440 Fax: 859-448-2622 |